Bristol-Myers Squibb (Q14345): Difference between revisions
Jump to navigation
Jump to search
Created claim: instance of (P2): public company (Q8826) |
Created claim: part of (P7): S&P 500 (Q8884) |
||||||||||||||
| Property / part of | |||||||||||||||
| Property / part of: S&P 500 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / part of: S&P 500 / qualifier | |||||||||||||||
start time: 4 March 1957
| |||||||||||||||
Revision as of 20:33, 5 October 2023
American pharmaceutical company
- BMS
- Bristol Myers Squibb
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bristol-Myers Squibb |
American pharmaceutical company |
|